JP4679854B2 - Sterilized bamboo fiber gauze - Google Patents
Sterilized bamboo fiber gauze Download PDFInfo
- Publication number
- JP4679854B2 JP4679854B2 JP2004249338A JP2004249338A JP4679854B2 JP 4679854 B2 JP4679854 B2 JP 4679854B2 JP 2004249338 A JP2004249338 A JP 2004249338A JP 2004249338 A JP2004249338 A JP 2004249338A JP 4679854 B2 JP4679854 B2 JP 4679854B2
- Authority
- JP
- Japan
- Prior art keywords
- bamboo fiber
- sterilized
- fiber gauze
- gauze
- polyethylene glycol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 235000017166 Bambusa arundinacea Nutrition 0.000 title claims description 48
- 235000017491 Bambusa tulda Nutrition 0.000 title claims description 48
- 241001330002 Bambuseae Species 0.000 title claims description 48
- 235000015334 Phyllostachys viridis Nutrition 0.000 title claims description 48
- 239000011425 bamboo Substances 0.000 title claims description 48
- 239000000835 fiber Substances 0.000 title claims description 47
- 230000001954 sterilising effect Effects 0.000 claims description 22
- 102000004190 Enzymes Human genes 0.000 claims description 19
- 108090000790 Enzymes Proteins 0.000 claims description 19
- 238000004659 sterilization and disinfection Methods 0.000 claims description 15
- 239000011550 stock solution Substances 0.000 claims description 15
- 230000000844 anti-bacterial effect Effects 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 8
- 150000008040 ionic compounds Chemical class 0.000 claims description 8
- 229940124272 protein stabilizer Drugs 0.000 claims description 8
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims description 8
- 229920001661 Chitosan Polymers 0.000 claims description 5
- 229940045110 chitosan Drugs 0.000 claims description 5
- 230000009089 cytolysis Effects 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 229940113116 polyethylene glycol 1000 Drugs 0.000 claims description 5
- 239000004744 fabric Substances 0.000 claims description 4
- 239000001103 potassium chloride Substances 0.000 claims description 4
- 235000011164 potassium chloride Nutrition 0.000 claims description 4
- 229910000160 potassium phosphate Inorganic materials 0.000 claims description 4
- 235000011009 potassium phosphates Nutrition 0.000 claims description 4
- 239000011780 sodium chloride Substances 0.000 claims description 4
- 229940068918 polyethylene glycol 400 Drugs 0.000 claims description 3
- 229940057838 polyethylene glycol 4000 Drugs 0.000 claims description 3
- 229940093429 polyethylene glycol 6000 Drugs 0.000 claims description 3
- 239000001488 sodium phosphate Substances 0.000 claims description 3
- 229910000162 sodium phosphate Inorganic materials 0.000 claims description 3
- 239000000243 solution Substances 0.000 claims description 3
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims description 3
- 239000004745 nonwoven fabric Substances 0.000 claims description 2
- 235000002639 sodium chloride Nutrition 0.000 claims description 2
- 235000011008 sodium phosphates Nutrition 0.000 claims description 2
- 238000006748 scratching Methods 0.000 claims 1
- 230000002393 scratching effect Effects 0.000 claims 1
- 239000002759 woven fabric Substances 0.000 claims 1
- 206010052428 Wound Diseases 0.000 description 23
- 208000027418 Wounds and injury Diseases 0.000 description 22
- 241000894006 Bacteria Species 0.000 description 7
- 229920000742 Cotton Polymers 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 230000035876 healing Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 241000233866 Fungi Species 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- 230000009429 distress Effects 0.000 description 2
- 230000002101 lytic effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000004753 textile Substances 0.000 description 2
- 241000589291 Acinetobacter Species 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241000588923 Citrobacter Species 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- TYMRLRRVMHJFTF-UHFFFAOYSA-N Mafenide Chemical compound NCC1=CC=C(S(N)(=O)=O)C=C1 TYMRLRRVMHJFTF-UHFFFAOYSA-N 0.000 description 1
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 1
- 206010046914 Vaginal infection Diseases 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000000181 anti-adherent effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229960003085 meticillin Drugs 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229940091629 sulfamylon Drugs 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
Description
本発明は竹繊維を原料として作られたガーゼ（すなわち、竹繊維ガーゼ）に関するものであり、具体的には、殺菌溶解液を含有する殺菌性を有する竹繊維ガーゼに関するものである。 The invention gauze (i.e., bamboo fiber gauze) made of bamboo fiber as raw material all SANYO relates, specifically, to a bamboo fiber gauze with a bactericidal containing sterilizing solution.
現在、臨床上皮膚科、外科、救急診療室等でよく使われているガーゼとしては一般的に以下のものがある。
（１）普通の医薬用滅菌ガーゼ。しかし、そのもの自体には抗菌性がなく抗癒着性もない。
（２）竹繊維を原料として作られた抗癒着性ガーゼ。傷口の癒着が防止できるが、あらゆる細菌に対し殺菌作用がある訳ではない。（特許文献１（ＣＮ １４６１８２７Ａ『天然抗菌材料及びその用途』）、特許文献２（特開２００３−３１０７２１号公報『竹繊維製抗菌性布帛』）参照。）
（３）従来の抗菌性ガーゼ。このものは抗菌物質を含有しているため、殺菌効果があり、傷口の治療または創傷面の感染防止ができるが、傷口または創傷面の抗癒着性の問題は解決できない。（特許文献３（ＣＮ １３６０９４９Ａ）『溶解ブドウ球菌複合酵素殺菌ガーゼ』）参照。）この殺菌ガーゼは非常に優れた殺菌効果があるが、創傷面での癒着問題があるので、患者に苦痛をもたらす可能性がある。
Currently, clinical dermatology, surgical, general, there are the following ones as gauze, which is often used in the emergency department room or the like.
(1) Ordinary pharmaceutical sterilized gauze . However , it itself has no antibacterial properties and no anti-adhesion properties .
(2) Anti-adhesive gauze made from bamboo fiber . Wound adhesion can be prevented, but not all bacteria are bactericidal . (Patent Document 1 (CN 1461827A "natural antimicrobial material and use thereof"), Patent Document 2 (JP 2003-310721 JP "bamboo textile antibacterial fabric") reference.)
(3) Conventional antibacterial gauze . Since it contains an antibacterial substance, it has a bactericidal effect and can treat the wound or prevent infection of the wound surface, but cannot solve the problem of anti-adhesion of the wound or wound surface . ( Patent Document 3 (CN 1360949A) “dissolved staphylococcal complex enzyme bactericidal gauze” ). ) This bactericidal gauze has a very good bactericidal effect, but it can cause pain to the patient due to adhesion problems on the wound surface.
本発明は、殺菌竹繊維ガーゼ及びその製造方法と応用を提供して、従来の殺菌ガーゼに付随していた創傷面での癒着問題を解決することを技術的課題とする。 An object of the present invention is to provide a sterilized bamboo fiber gauze and a manufacturing method and application thereof, and to solve the problem of adhesion on a wound surface associated with a conventional sterilized gauze .
本発明は、殺菌原液の組成分及びその重量パーセンテージが、
溶解ブドウ球菌酵素 ０．００１−１％
溶解菌酵素 ０．１−２０％
タンパク質安定剤 ０．２−５０％
イオン化合物 ０．５−１０％
水 他
からなり、
前記タンパク質安定剤は、キトサン、ポリエチレングリコール４００、ポリエチレングリコール１０００、ポリエチレングリコール４０００或いはポリエチレングリコール６０００の中の一種或いは二種以上であり、
前記イオン化合物は塩化ナトリウム、塩化カリウム、リン酸カリウム或いはリン酸ナトリウムの中の一種或いは二種以上であり、
竹繊維ガーゼが前記殺菌原液を含有していることを特徴とする殺菌竹繊維ガーゼにより上述の課題を達成する。
In the present invention, the composition of the sterilization stock solution and its weight percentage are
Dissolved staphylococcal enzyme 0.001-1%
Lysis enzyme 0.1-20%
Protein stabilizer 0.2-50%
Ionic compounds 0.5-10%
Water and others
Consists of
The protein stabilizer is one or more of chitosan, polyethylene glycol 400, polyethylene glycol 1000, polyethylene glycol 4000 or polyethylene glycol 6000,
The ionic compound is one or more of sodium chloride, potassium chloride, potassium phosphate or sodium phosphate,
The above-mentioned problem is achieved by a sterilized bamboo fiber gauze characterized in that the bamboo fiber gauze contains the sterilized stock solution.
本発明に係る殺菌竹繊維ガーゼによれば、創傷面での抗癒着性を発現し、患者には癒着による苦痛を与えず、創傷面の治癒時間の大幅短縮ができる。 According to the sterilized bamboo fiber gauze according to the present invention , the anti-adhesion property on the wound surface is expressed, the patient is not caused by the adhesion pain, and the healing time of the wound surface can be greatly shortened.
本発明における殺菌原液の最適な浸し量は、４枚あわせ竹繊維ガーゼ１００ｃｍ ２ 当たり４−６ｍｌである。
本発明における殺菌原液の組成分及び重量パーセンテージは以下の通りである。
溶解ブドウ球菌酵素 ０．００１−１％
溶解菌酵素 ０．１−２０％
タンパク質安定剤 ０．２−５０％
イオン化合物 ０．５−１０％
水 他。
より好ましくは、本発明の殺菌原液の組成分及び重量パーセンテージは以下の通りである。
溶解ブドウ球菌酵素 ０．０１−０．１％
溶解菌酵素 ２−１０％
タンパク質安定剤 ５−４０％
イオン化合物 ０．５−１％
水 他。
上記タンパク質安定剤は、キトサン、ポリエチレングリコール４００、ポリエチレングリコール１０００、ポリエチレングリコール４０００或いはポリエチレングリコール６０００の中の一種或いは二種以上である。
また、上記イオン化合物は、塩化ナトリウム、塩化カリウム、リン酸カリウム或いはリン酸ナトリウムの中の一種或いは二種以上である。
The optimal amount of sterilization stock solution in the present invention is 4-6 ml per 100 cm 2 of bamboo fiber gauze .
The composition fraction and weight percentage of sterilizing concentrate of the present invention is Ri following passage.
Dissolved staphylococcal enzyme 0.001-1%
Lysis enzyme 0.1-20%
Protein stabilizer 0.2-50%
Ionic compounds 0.5-10%
Water and others .
More preferably, the composition and weight percentage of the sterilization stock solution of the present invention are as follows .
Dissolved staphylococcal enzyme 0.01-0.1%
Lysis enzyme 2-10%
Protein stabilizer 5-40%
Ionic compounds 0.5-1%
Water and others .
The protein stabilizers, chitosan, polyethylene glycol 400, polyethylene glycol 1000, is one or two or more of the polyethylene glycol 4000 or polyethylene glycol 6000.
Further, the ionic compound is sodium chloride, potassium chloride, one of: potassium phosphate or sodium phosphate, or two or more kinds.
本発明の殺菌竹繊維ガーゼの製造に際しては、竹繊維ガーゼを上記殺菌原液の中に浸す。４枚あわせの竹繊維ガーゼ１００ｃｍ ２ 当たり１−１０ｍｌの殺菌原液を含有させる。 The production of the sterilizing bamboo fiber gauze of the present invention, soaking the bamboo fiber gauze into the sterilization stock. 1-10 ml of sterilization stock solution is contained per 100 cm 2 of 4 pieces of bamboo fiber gauze .
本発明の殺菌竹繊維ガーゼは、創傷面傷当て材、またはベビー用または大人用紙オムツ、ナプキン、マスクなどの衛生材料全般に活用できるものであり、竹繊維ガーゼは織物、編物、不織布として作ることができる。 Sterilization bamboo fiber gauze of the present invention, the wound surface scratches against material, or a baby or adult for Kamio diaper, napkin, which can be utilized for sanitary materials in general, such as a mask, bamboo fiber gauze fabric, knitted fabric, as non-woven fabric Can be made.
本発明に使用される竹繊維ガーゼは、日本の株式会社ナファ生活研究所または中国上海天竹紡績繊維有限公司が生産する竹繊維ガーゼによるものである。 Bamboo fiber gauze to be used in the present invention is, Japan Co., Ltd. Nafa living laboratory or China Shanghai guinea Textile Textile Co., Ltd is due to bamboo fiber gauze to produce.
本発明に使用される溶解ブドウ球菌酵素は、中国上海高科生物工程有限公司が生産したものまたは米国ＳＩＧＭＡ社から購入する溶解ブドウ球菌酵素によるものである。 The lytic staphylococcal enzyme used in the present invention is one produced by Shanghai High Science Biological Process Co., Ltd. , China, or by lytic staphylococcal enzyme purchased from SIGMA, USA.
本発明による殺菌竹繊維ガーゼには非常に優れた殺菌効果を持っており、体外でよく見かける細菌菌株を使って５分間の実験をした（実験方法は２００２年第四版《消毒技術規範》を参照）、実験結果は以下の通りである。
そのほか臨床で採集した２種類の良く見かける耐薬性菌菌株（黄色ブドウ球菌と緑膿菌）を使って上述と同じように５分間の殺菌実験を行い、殺菌率はそれぞれ９９．９５％と９９．９６％であった。
また、中国上海長海医院やけど科で２０例の創傷面細菌感染の患者に対して、臨床テストを行い、殺菌竹繊維ガーゼが創傷面感染菌に対する殺菌効果と殺菌竹繊維ガーゼが創傷面傷口に対する癒着性を観察した、結果は以下の通りである。
やけど創傷面に多く存在する菌株はメチシリン耐性黄色ブドウ球菌（ＭＲＳＡ）、緑膿菌、肺炎桿菌、アシネトバクター菌、Ｃｉｔｒｏ Ｂａｃｔｅｒ菌とカンジタ菌であり、普通の医薬用ガーゼに５％のＳｕｌｆａｍｙｌｏｎ溶解液に浸して対照テストとし、実験前とガーゼを使用後７２時間後創傷面にてサンプルを採集して、細菌を培養し、実験前後の殺菌率を比較し、結果は以下の通りである。
In addition, a clinical test was conducted on 20 wound surface bacterial infection patients in Changhai Clinic, Shanghai, China. Bactericidal bamboo fiber gauze was effective against bacterial wound infection bacteria and bactericidal bamboo fiber gauze was effective against wound wounds. was observed adhesion results are Ri following passage.
The most common strains on burn wounds are methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa, Klebsiella pneumoniae, Acinetobacter, Citro Bacter and Candida. As a control test, the sample was collected on the wound surface before the experiment and 72 hours after using the gauze, the bacteria were cultured, and the sterilization rate before and after the experiment was compared. The results are as follows.
図１および図２に示すように、竹繊維と綿繊維とでは構造上異なっている。綿繊維は中空状であるのに対し、図２に示すように、竹繊維は表面は溝状であり、竹繊維の表面には多数の凹凸がある。綿繊維はその中空部分で水分を吸収するのに対し、竹繊維は表面の溝の部分で水分を吸収すると同時に、竹繊維表面の凹凸が皮膚とガーゼの間の『クッション材』となる。したがって、竹繊維は傷口に対して抗癒着の働きがあり、本発明の殺菌竹繊維ガーゼはガーゼを取り替える際の患者の苦痛を和らげる効果があり、傷口の回復にも有利である。
本発明者は、普通の医薬用綿ガーゼと本発明の殺菌竹繊維ガーゼとを使って、創傷面に対する癒着性の比較臨床テストを行った。
普通の医薬用綿ガーゼを創傷面に使っている場合には、ガーゼを取り替える際に患者に苦痛を与え、治りかけの傷口またはその一部は再び開き、傷口の治癒には本来の治癒以上の時間を要した。
これに対して、本発明の殺菌竹繊維ガーゼは竹繊維の特殊性能により、ガーゼは創傷面と癒着せず、患者には苦痛を与えることなく、創傷面の治癒時間の大幅短縮ができる。
臨床観察の中で、いかなる不良反応もなかったことから、本発明の殺菌竹繊維ガーゼは治療の効果が良く、患者に対し刺激性等の毒性副作用がなく、臨床で幅広く応用できることが立証された。以下はその実施例である。
As shown in FIGS. 1 and 2, bamboo fiber and cotton fiber are structurally different. The cotton fiber is hollow , whereas the bamboo fiber has a groove shape as shown in FIG. 2 , and the surface of the bamboo fiber has a number of irregularities . Cotton fibers whereas absorbs water in its hollow portion, bamboo fiber and simultaneously absorbs moisture in the groove of the surface irregularities of the bamboo fiber surface becomes "cushion material" between the skin and the gauze. Therefore, bamboo fiber has an anti-adhesion action on the wound, and the sterilized bamboo fiber gauze of the present invention has an effect of relieving the patient's pain when replacing the gauze, and is advantageous for recovery of the wound.
The present inventor uses the usual sterilization bamboo fiber gauze pharmaceutical cotton gauze and the present invention was performed adhesion of controlled clinical tests on wound surface.
In the case where an ordinary pharmaceutical cotton gauze are using the wound surface, the pain and distress to the patient when to replace the gauze, of over a period of healing open wound, or a portion thereof again, the wound healing more than the original healing It took time.
In contrast, the sterilized bamboo fiber gauze special performance of bamboo fiber of the present invention, gauze without adhesion with the wound surface, without Rukoto the pain and distress to the patient, can considerably shorten the healing time of the wound surface.
Among the clinical observations, since there was no any adverse reactions, sterilized bamboo fiber gauze present invention has good effects of treatment, without any toxic side effects, such as irritation to the patient, is established that can be widely applied in clinical It was . The following is an example.
実施例１
溶解ブドウ球菌酵素 ０．００１グラム
溶解菌酵素 ３グラム
キトサン １０グラム
塩化ナトリウム ０．９グラム
水 他。
１００ｍｌの殺菌原液を作り、１４ｃｍ×７ｃｍの４枚あわせの竹繊維ガーゼを５ｍｌの殺菌原液の中に浸し、これを皮膚科、外科、産婦人科等身体表面の創傷面の診療科で、創傷面の細菌と真菌の感染の予防または治療に使った。創傷面の治癒を促進し、治療時間を短縮する効果が認められた。
Example 1
Dissolved Staphylococcus aureus enzyme 0.001 g dissolved bacteria enzyme 3 g chitosan 10 g sodium chloride 0.9 g Water other.
Make 100ml sterilization stock solution, immerse 4cm bamboo fiber gauze of 14cm x 7cm in 5ml sterilization stock solution, and use this for dermatology, surgery, gynecology, etc. was Tsu used in the prevention or treatment of infection of the surface of bacteria and fungi. The effect of promoting healing of the wound surface and shortening the treatment time was observed .
実施例２
溶解ブドウ球菌酵素 ０．１グラム
溶解菌酵素 １０グラム
キトサン ５グラム
ポリエチレングリコール１０００ ２グラム
塩化カリウム １グラム
水 他。
１００ｍｌの殺菌原液を作り、１４ｃｍ×７ｃｍの４枚あわせの竹繊維ガーゼを２ｍｌの殺菌原液の中に浸し、これをベビー及び大人用紙オムツの中に使った。幼児や介護老人の細菌と真菌の感染の予防ができる効果が認められた。
Example 2
Dissolved staphylococcal enzyme 0.1 grams Dissolved bacterial enzyme 10 grams Chitosan 5 grams Polyethylene glycol 1000 2 grams Potassium chloride 1 gram Water, etc.
Create a sterilization stock solution of 100ml, soak the bamboo fiber gauze of 4-ply of 14cm × 7cm in the sterilization stock solution of 2ml, which was Tsu used in the baby and adult paper diapers. Effect that can prevent the infection of bacteria and fungi of infants and nursing old man was found.
実施例３
溶解ブドウ球菌酵素 ０．０１グラム
溶解菌酵素 ８グラム
ポリエチレングリコール１０００ ６グラム
リン酸カリウム ０．７グラム
水 他
１００ｍｌの殺菌原液を作り、１４ｃｍ×７ｃｍの４枚あわせの竹繊維ガーゼを４ｍｌの殺菌原液の中に浸し、これを女性用ナプキンの中に使った。膣感染の予防ができる効果が認められた。
Example 3
Dissolved staphylococcal enzyme 0.01 gram Dissolved bacterium enzyme 8 gram Polyethylene glycol 1000 6 gram Potassium phosphate 0.7 gram Water, etc. Make 100 ml of sterilized stock solution, and 4 ml of 14 cm x 7 cm bamboo fiber gauze together with 4 ml of sterilized stock solution dip them in, which was Tsu used in a feminine napkin. The effect which can prevent vaginal infection was recognized .
Claims (6)
溶解ブドウ球菌酵素 ０．００１−１％
溶解菌酵素 ０．１−２０％
タンパク質安定剤 ０．２−５０％
イオン化合物 ０．５−１０％
水 他
からなり、
前記タンパク質安定剤は、キトサン、ポリエチレングリコール４００、ポリエチレングリコール１０００、ポリエチレングリコール４０００或いはポリエチレングリコール６０００の中の一種或いは二種以上であり、
前記イオン化合物は塩化ナトリウム、塩化カリウム、リン酸カリウム或いはリン酸ナトリウムの中の一種或いは二種以上であり、
竹繊維ガーゼが前記殺菌原液を含有していることを特徴とする殺菌竹繊維ガーゼ。 The composition of the sterilization stock solution and its weight percentage are
Dissolved staphylococcal enzyme 0.001-1%
Lysis enzyme 0.1-20%
Protein stabilizer 0.2-50%
Ionic compounds 0.5-10%
Water and others
Consists of
The protein stabilizer is one or more of chitosan, polyethylene glycol 400, polyethylene glycol 1000, polyethylene glycol 4000 or polyethylene glycol 6000,
The ionic compound is one or more of sodium chloride, potassium chloride, potassium phosphate or sodium phosphate,
Bactericidal bamboo fiber gauze characterized in that the bamboo fiber gauze contains the sterilizing stock solution.
溶解ブドウ球菌酵素 ０．０１−０．１％
溶解菌酵素 ２−１０％
タンパク質安定剤 ５−４０％
イオン化合物 ０．５−１％
水 他
からなり、竹繊維ガーゼが前記殺菌原液を含有をしていることを特徴とする請求項１に記載の殺菌竹繊維ガーゼ。 The composition fraction and weight percentage of the sterilizing stock solution,
Dissolved staphylococcal enzyme 0.01-0.1%
Lysis enzyme 2-10%
Protein stabilizer 5-40%
Ionic compounds 0.5-1%
Water and others
The sterilized bamboo fiber gauze according to claim 1, characterized in that the bamboo fiber gauze contains the sterilized stock solution.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004249338A JP4679854B2 (en) | 2004-08-03 | 2004-08-03 | Sterilized bamboo fiber gauze |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004249338A JP4679854B2 (en) | 2004-08-03 | 2004-08-03 | Sterilized bamboo fiber gauze |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006043370A JP2006043370A (en) | 2006-02-16 |
| JP4679854B2 true JP4679854B2 (en) | 2011-05-11 |
Family
ID=36022560
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004249338A Expired - Lifetime JP4679854B2 (en) | 2004-08-03 | 2004-08-03 | Sterilized bamboo fiber gauze |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4679854B2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5096736B2 (en) * | 2006-12-13 | 2012-12-12 | ユニ・チャーム株式会社 | Absorbent articles |
| US7744143B2 (en) | 2007-01-10 | 2010-06-29 | Federal Mogul Powertrain | Nonwoven panel and method of construction thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1360949A (en) * | 2000-12-28 | 2002-07-31 | 上海高科生物工程有限公司 | Bactericidal gauze with lysostaphin complex enzyme |
| JP2003310721A (en) * | 2002-04-25 | 2003-11-05 | Miyo Kk | Antibacterial cloth made of bamboo fibers |
| CN1461827A (en) * | 2002-05-31 | 2003-12-17 | 余钢纲 | Natural antibacterial material and its use |
-
2004
- 2004-08-03 JP JP2004249338A patent/JP4679854B2/en not_active Expired - Lifetime
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1360949A (en) * | 2000-12-28 | 2002-07-31 | 上海高科生物工程有限公司 | Bactericidal gauze with lysostaphin complex enzyme |
| JP2003310721A (en) * | 2002-04-25 | 2003-11-05 | Miyo Kk | Antibacterial cloth made of bamboo fibers |
| CN1461827A (en) * | 2002-05-31 | 2003-12-17 | 余钢纲 | Natural antibacterial material and its use |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2006043370A (en) | 2006-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4481372B2 (en) | Bactericidal plastic sponge material | |
| US8632823B2 (en) | Treatment of infected tissues with hypochlorous acid | |
| EP2217287B1 (en) | Hygiene or care item comprising a moiety of hydro-active polymers, and preparation containing bacteriophages or at least one component thereof | |
| CN103889468B (en) | Multi-layer wound dressings comprising hydrocolloid and activated carbon | |
| Dowsett | The use of silver-based dressings in wound care | |
| DE69018684T2 (en) | Antimicrobial plastic materials with broadband effect. | |
| Laufman | Current use of skin and wound cleansers and antiseptics | |
| JP6290184B2 (en) | Wound dressing | |
| ES2423730T3 (en) | Use of a synergistic composition as a therapeutic agent or disinfection agent | |
| RU2611046C2 (en) | Composition with antibacterial and wound-healing activity | |
| CN111068103A (en) | Long-acting antibacterial gel dressing for operation wound and preparation method thereof | |
| Mitchell | Use of Manuka honey for autolytic debridement in necrotic and sloughy wounds | |
| JP4679854B2 (en) | Sterilized bamboo fiber gauze | |
| CN1596991B (en) | Sterilization bamboo fiber gauze and its preparation method and application | |
| JP2005501016A (en) | Antibacterial material | |
| KR20030008048A (en) | Disposable diaper comprising antibacterial and deodorizing agent | |
| Teot et al. | The management of wounds using Silvercel hydroalginate | |
| Knowles | 15 Dressings: Is There an Evidence Base? | |
| Scott et al. | The comparative value of metaphen in alcohol-acetone-aqueous solutions in the pre-operative disinfection of the skin | |
| Weir et al. | Dressings in wound care | |
| KR200374914Y1 (en) | Nano silver contain wound dressing | |
| RU10570U1 (en) | DEVICE FOR TREATMENT OF SURFACE PURULO-INFLAMMATORY DISEASES OF THE UPLING RING IN CHILDREN | |
| Babu et al. | Application of Di Alkyl Carbamoyl Chloride (DACC) Technology in the Management of Infection in Chronic Wounds | |
| O'Dwyer | The role of antimicrobial wound dressings. | |
| KR20040082357A (en) | Nano silver contain wound dressing |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20070730 |
|
| RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20070730 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070801 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20101130 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110111 Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20110111 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20110201 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20110202 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 4679854 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140210 Year of fee payment: 3 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |